Oceania Healthcare (OCA) reported a mixed FY23 result which included some clear positives and some clear negatives; On the positive side, record high new sales margins and pricing were a standout, demonstrating that the product that OCA is bringing to market can fetch premium pricing
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.